SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Conocophillips – ‘10-Q’ for 3/31/16 – ‘EX-10.5’

On:  Tuesday, 5/3/16, at 11:11am ET   ·   For:  3/31/16   ·   Accession #:  1193125-16-574165   ·   File #:  1-32395

Previous ‘10-Q’:  ‘10-Q’ on 11/3/15 for 9/30/15   ·   Next:  ‘10-Q’ on 8/2/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/03/16  Conocophillips                    10-Q        3/31/16   95:8.9M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    767K 
 2: EX-10.1     Material Contract                                   HTML     27K 
 3: EX-10.2     Material Contract                                   HTML     93K 
 4: EX-10.3     Material Contract                                   HTML     48K 
 5: EX-10.4     Material Contract                                   HTML     46K 
 6: EX-10.5     Material Contract                                   HTML     46K 
 7: EX-12       Statement re: Computation of Ratios                 HTML     33K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
10: EX-32       Certification -- §906 - SOA'02                      HTML     27K 
17: R1          Document and Entity Information                     HTML     46K 
18: R2          Consolidated Income Statement                       HTML    106K 
19: R3          Consolidated Statement of Comprehensive Income      HTML     76K 
20: R4          Consolidated Balance Sheet                          HTML    122K 
21: R5          Consolidated Balance Sheet (Parenthetical)          HTML     41K 
22: R6          Consolidated Statement of Cash Flows                HTML    113K 
23: R7          Basis of Presentation                               HTML     31K 
24: R8          Change in Accounting Principles                     HTML     33K 
25: R9          Variable Interest Entities (VIEs)                   HTML     31K 
26: R10         Inventories                                         HTML     41K 
27: R11         Assets Held for Sale or Sold                        HTML     32K 
28: R12         Investments, Loans and Long-Term Receivables        HTML     40K 
29: R13         Suspended Wells and Wells in Progress               HTML     30K 
30: R14         Impairments                                         HTML     41K 
31: R15         Debt                                                HTML     46K 
32: R16         Noncontrolling Interests                            HTML     58K 
33: R17         Guarantees                                          HTML     45K 
34: R18         Contingencies and Commitments                       HTML     50K 
35: R19         Derivative and Financial Instruments                HTML    113K 
36: R20         Fair Value Measurement                              HTML    128K 
37: R21         Accumulated Other Comprehensive Income              HTML     50K 
38: R22         Cash Flow Information                               HTML     36K 
39: R23         Employee Benefit Plans                              HTML     75K 
40: R24         Related Party Transactions                          HTML     41K 
41: R25         Segment Disclosures and Related Information         HTML     73K 
42: R26         Income Taxes                                        HTML     34K 
43: R27         New Accounting Standards                            HTML     33K 
44: R28         Supplementary Information - Condensed               HTML    454K 
                Consolidating Financial Information                              
45: R29         Inventories (Tables)                                HTML     37K 
46: R30         Impairments (Tables)                                HTML     37K 
47: R31         Noncontrolling Interests (Tables)                   HTML     57K 
48: R32         Derivative and Financial Instruments (Tables)       HTML    100K 
49: R33         Fair Value Measurement (Tables)                     HTML    124K 
50: R34         Accumulated Other Comprehensive Income (Tables)     HTML     49K 
51: R35         Cash Flow Information (Tables)                      HTML     34K 
52: R36         Employee Benefit Plans (Tables)                     HTML     71K 
53: R37         Related Party Transactions (Tables)                 HTML     38K 
54: R38         Segment Disclosures and Related Information         HTML     65K 
                (Tables)                                                         
55: R39         Supplementary Information - Condensed               HTML    451K 
                Consolidating Financial Information (Tables)                     
56: R40         Inventories (Details)                               HTML     39K 
57: R41         Assets Held for Sale or Sold (Details)              HTML     39K 
58: R42         Investments, Loans and Long-Term Receivables        HTML     64K 
                (Details)                                                        
59: R43         Suspended Wells and Wells in Progress (Details)     HTML     32K 
60: R44         Impairments (Details)                               HTML     42K 
61: R45         Debt (Details Textual)                              HTML     81K 
62: R46         Noncontrolling Interests (Details)                  HTML     49K 
63: R47         Guarantees (Details)                                HTML     64K 
64: R48         Contingencies and Commitments (Details)             HTML     32K 
65: R49         Derivative and Financial Instruments - Commodity    HTML     38K 
                Balance Sheet (Details)                                          
66: R50         Derivative and Financial Instruments - Commodity    HTML     34K 
                GainLoss (Details 1)                                             
67: R51         Derivative and Financial Instruments - Commodity    HTML     32K 
                Notional (Details 2)                                             
68: R52         Derivative and Financial Instruments - FX Balance   HTML     34K 
                Sheet (Details 3)                                                
69: R53         Derivative and Financial Instruments - FX GainLoss  HTML     31K 
                (Details 4)                                                      
70: R54         Derivative and Financial Instruments - FX Notional  HTML     37K 
                (Details 5)                                                      
71: R55         Derivative and Financial Instruments - Financial    HTML     48K 
                Instruments (Details 6)                                          
72: R56         Derivative and Financial Instruments (Details       HTML     41K 
                Textual)                                                         
73: R57         Fair Value Measurement - FV Hierarchy (Details)     HTML     49K 
74: R58         Fair Value Measurement - FV of Commodity            HTML     69K 
                Derivatives (Details 1)                                          
75: R59         Faire Value Measurement - Nonrecurring (Details)    HTML     34K 
76: R60         Fair Value Measurement - FV of Fin. Instruments     HTML     57K 
                (Details 2)                                                      
77: R61         Accumulated Other Comprehensive Income (Loss)       HTML     50K 
                (Details)                                                        
78: R62         Accumulated Other Comprehensive Income (Loss)       HTML     31K 
                (Details 1)                                                      
79: R63         Cash Flow Information (Details)                     HTML     42K 
80: R64         Employee Benefit Plans (Details)                    HTML     55K 
81: R65         Employee Benefit Plans (Details Textual)            HTML     73K 
82: R66         Employee Benefit Plans (Severances)                 HTML     43K 
83: R67         Related Party Transactions (Details)                HTML     36K 
84: R68         Segment Disclosures and Related Information -       HTML     52K 
                Sales (Details)                                                  
85: R69         Segment Disclosures and Related Information - Net   HTML     45K 
                Income (Details 1)                                               
86: R70         Segment Disclosures and Related Information         HTML     28K 
                (Details Textual)                                                
87: R71         Segment Disclosures and Related Information -       HTML     42K 
                Assets (Details 2)                                               
88: R72         Income Taxes (Details)                              HTML     38K 
89: R73         Supplementary Information - Condensed               HTML    153K 
                Consolidating Financial Information - Inc Stmt                   
                (Details)                                                        
90: R74         Supplementary Information - Condensed               HTML    178K 
                Consolidating Financial Information - Bal Sheet                  
                (Details 1)                                                      
91: R75         Supplementary Information - Condensed               HTML     34K 
                Consolidating Financial Information - Bal Sheet                  
                (Details Textual)                                                
92: R76         Supplementary Information - Condensed               HTML    134K 
                Consolidating Financial Information - Cash Flow                  
                (Details 2)                                                      
94: XML         IDEA XML File -- Filing Summary                      XML    165K 
93: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
11: EX-101.INS  XBRL Instance -- cop-20160331                        XML   3.05M 
13: EX-101.CAL  XBRL Calculations -- cop-20160331_cal                XML    227K 
14: EX-101.DEF  XBRL Definitions -- cop-20160331_def                 XML    758K 
15: EX-101.LAB  XBRL Labels -- cop-20160331_lab                      XML   1.76M 
16: EX-101.PRE  XBRL Presentations -- cop-20160331_pre               XML   1.30M 
12: EX-101.SCH  XBRL Schema -- cop-20160331                          XSD    209K 
95: ZIP         XBRL Zipped Folder -- 0001193125-16-574165-xbrl      Zip    218K 


‘EX-10.5’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-10.5  

Exhibit 10.5

NON-EMPLOYEE DIRECTOR

RESTRICTED STOCK UNITS

TERMS AND CONDITIONS

(Norwegian Non-Employee Directors)

This document sets forth the terms and conditions of the Restricted Stock Unit Award made as of the 15th day of January, 2016 (the “Grant Date”) by ConocoPhillips, a Delaware corporation (the “Company”) to                  (the “Grantee”) pursuant to the Resolutions approved by the Board of Directors on July 1, 2003September 22, 2004February 4, 2005November 18, 2005October 4, 2006December 3, 2010April 4, 2012, and December 6, 2013.

 

1.

Award. Effective as of the Grant Date, the Company awarded to the Grantee              Restricted Stock Units. The number of units was determined by dividing the value of the equity compensation payable on the Grant Date by the fair market value on the Grant Date (as fair market value is determined under the 2014 Omnibus Stock and Performance Incentive Plan of ConocoPhillips), and rounding up to the next whole unit.

 

2.

Restrictions. The Restricted Stock Units granted to the Grantee may not be sold, assigned, transferred, pledged, or otherwise encumbered from the Grant Date until the date the Grantee obtains a vested right to the units (and the restrictions thereon terminate) in accordance with these provisions.

The Grantee shall have a vested right to settlement of all of the Restricted Stock Units, including additional Restricted Stock Units issued as a result of dividend equivalents being reinvested during the Restriction Period, upon separation from service, whether by death, disability, retirement, or otherwise, with the Board of Directors of ConocoPhillips. Notwithstanding the foregoing, Grantee shall also have a vested right to settlement of all of the Restricted Stock Units upon a Change of Control, however, in this event, the Restricted Stock Units shall not be settled in unrestricted stock until separation from service.

The period of time between the Grant Date and the date that the Restricted Stock Units are settled as unrestricted stock shall be referred to as the “Restriction Period” as to those Units. In the event that any day on which the Grantee would otherwise receive unrestricted shares is a Saturday, Sunday, or holiday, the Grantee shall instead receive the unrestricted shares on the first business day immediately following such date.

 

- 1 -


3.

Dividend Equivalents. If a regular cash dividend on the Common Stock of ConocoPhillips, par value of $.01 per share, is declared by the Board of Directors of ConocoPhillips with a record date that occurs during the Restriction Period, a Dividend Equivalent equal to the value of the dividend or other distribution shall be reinvested in additional Restricted Stock Units as of the date such dividends are payable and such additional Restricted Stock Units shall be subject to the same terms and conditions as the Grant of Restricted Stock Units. The number of Restricted Stock Units acquired through this reinvestment of Dividend Equivalents shall be calculated in basically the same manner as the Company’s Dividend Reinvestment Program. The Restricted Stock Units are not eligible for any dividend equivalent payments with regard to any extraordinary cash dividends on the Common Stock of ConocoPhillips, par value of $.01 per share, that may be declared by the Board of Directors of ConocoPhillips.

 

4.

Forfeiture. Notwithstanding anything herein to the contrary, if prior to settlement of the Restricted Stock Units as unrestricted stock, the Board of Directors finds sufficient cause, in its absolute discretion, it may resolve to forfeit any or all of the Restricted Stock Units held for the Grantee; provided, however, that this provision shall not apply after a Change of Control has occurred. Such forfeiture shall apply to Beneficiaries as well as the Grantee.

 

5.

Voting Rights. The Grantee has no voting rights or other interests in shares of Common Stock of ConocoPhillips as a result of having this Award.

 

6.

Settlement. After the end of the Restriction Period, the Grantee will receive unrestricted shares of ConocoPhillips stock in the same number as the Restricted Stock Units, and the Restricted Stock Units shall be canceled. The date of such settlement is referred to as the “Settlement Date.” Any fractional shares shall be paid in cash at the fair market value on the Settlement Date. Unrestricted shares of ConocoPhillips Common Stock shall be distributed to the Grantee not later than March 15 of the calendar year following the end of the Restriction Period.

 

7.

Taxes. In general terms, under current U.S. and Norwegian tax laws, it appears that the value of the Units is not considered taxable income to the Grantee until the restrictions lapse and settlement in ConocoPhillips Common Stock is made.

At the time the Restricted Stock Units are to be settled, the Company shall have the right to withhold an appropriate amount of cash or the number of shares of Common Stock, or combination of both, for payment of taxes or other amounts required by law or to take such action as may be necessary in the opinion of the Company to satisfy all obligations for withholding of taxes.

 

- 2 -


8.

Beneficiary Designations. The Grantee shall file with the Company on such form as may be prescribed by the Company, a designation of one or more beneficiaries and, if desired, one or more contingent beneficiaries (each referred to herein as a “Beneficiary”) to whom settlement of the Restricted Stock Units or Restricted Stock otherwise due the Grantee under the provisions of the Restricted Stock Unit Award shall be distributed in the event of the death of the Grantee. The Grantee shall have the right to change the Beneficiary or Beneficiaries. After receipt by the Company, the beneficiary designation shall take effect as of the date on which this form was signed by the Grantee, whether or not he or she is living at the time of such receipt but without prejudice to the Company on account of any payment made before receipt thereof.

If the Grantee has designated more than one beneficiary, settlement will be made in equal shares to such of the designated beneficiaries as survive the Grantee, unless the Grantee has designated otherwise on the Beneficiary Designation Form. If no designated beneficiary survives the Grantee, settlement will be made in the following order of priority: (i) the Grantee’s surviving spouse; (ii) the Grantee’s estate. Any beneficiary designation for Restricted Stock received by the Company shall also apply to Restricted Stock Units, and vice versa. The most recent beneficiary designation made by the Grantee shall be given effect as to all Restricted Stock or Restricted Stock Units granted to the Grantee as compensation for services rendered as a non-employee director of the Company.

 

9.

Nonalienation of Benefits. Except as contemplated by Section 9 above, no right or benefit under this Agreement shall be subject to transfer, anticipation, alienation, sale, assignment, pledge, encumbrance, or charge, whether voluntary, involuntary, or by operation of law, and any attempt to transfer, anticipate, alienate, sell, assign, pledge, encumber, or charge the same shall be void. No right or benefit hereunder shall in any manner be liable for or subject to any debts, contracts, liabilities, or torts of the person entitled to such benefits. If the Grantee or the Grantee’s Beneficiary hereunder shall become bankrupt or attempt to transfer, anticipate, alienate, assign, sell, pledge, encumber, or charge any right or benefit hereunder, other than as contemplated by Section 9 above, or if any creditor shall attempt to subject the same to a writ of garnishment, attachment, execution, sequestration, or any other form of process or involuntary lien or seizure, then such right or benefit shall cease and terminate.

 

10.

Prerequisites to Benefits. Neither the Grantee, nor any person claiming through the Grantee, shall have any right or interest in the Restricted Stock Units awarded hereunder, unless and until all the terms, conditions, and provisions that affect the Grantee or such other person shall have been complied with as specified herein.

 

- 3 -


11.

Delivery of Shares. In the event the Company has not obtained shareholder approval of a plan providing for delivery of stock, the Company shall not be obligated to deliver any shares of Common Stock if counsel to the Company determines that such sale or delivery would violate any applicable law or any rule or regulation of any governmental authority or any rule or regulation of, or agreement of the Company with, any securities exchange or association upon which the Common Stock is listed or quoted. If necessary to comply with any such law, rule, regulation, or agreement, the Company shall in no event be obligated to take any affirmative action in order to cause the delivery of shares of Common Stock. If the Company is unable in accordance with this paragraph to deliver stock in settlement, the Company may substitute payment in cash at the fair market value of the Restricted Stock Units on the Settlement Date.

 

12.

Rights as a Stockholder. The Grantee (or Beneficiary) does not have any rights as a stockholder with respect to the Restricted Stock Units.

 

13.

Adjustments. If the Common Stock of the Company is changed into or exchanged for a different number or kind of shares or securities, as the result of any one or more reorganizations, recapitalizations, stock splits, reverse stock splits, stock dividends or similar events, or in the event of a sale by the Company of all or a significant part of its assets, or any distribution to its shareholders other than a regular cash dividend or extraordinary cash dividends, a corresponding adjustment shall be made in the number of Restricted Stock Units under this Award.

 

14.

Amendment. Without the consent of the Grantee, the provisions of this Award may be amended or supplemented (i) to cure any ambiguity or to correct or supplement any provision herein which may be defective or inconsistent with any other provision herein, or (ii) to add to the covenants and agreements of the Company for the benefit of Grantee or to add to the rights of the Grantee or to surrender any right or power reserved to or conferred upon the Company in this Agreement, subject, however, to any required approval of the Company’s stockholders and, provided, in each case, that such changes or corrections shall not adversely affect the rights of Grantee with respect to the Award evidenced hereby without the Grantee’s consent, or (iii) to make such other changes as the Company, upon advice of counsel, determines are necessary or advisable because of the adoption or promulgation of, or change in or of the interpretation of, any law or governmental rule or regulation, including any applicable federal or state securities laws.

 

15.

Grantee Service. Nothing contained in this Agreement, and no action of the Company or the Committee with respect hereto, shall confer or be construed to confer on the Grantee any right to continue as a Non-Employee Director of the Company.

 

- 4 -


16.

Governing Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Delaware.

 

17.

Definitions. For purposes of this Award, Separation from Service and Change of Control are defined as follows:

 

  (a)

Separation from Service is the termination of Board service, provided that such term shall be interpreted to accord with the term “separation from service” as used in section 409A of the Internal Revenue Code of the United States, as may be amended from time to time.

 

  (b)

Change of Control shall have the same meaning as set forth in the 2014 Omnibus Stock and Performance Incentive Plan of ConocoPhillips, except that the measurement date shall be changed from May 13, 2014, to the Grant Date.

 

- 5 -


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/3/164
For Period end:3/31/164
5/13/143,  8-K,  DEF 14A
12/6/138-K
4/4/124,  8-K
12/3/10
10/4/068-K
11/18/054
2/4/054,  8-K
9/22/048-K
7/1/03
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/15/24  ConocoPhillips                    10-K       12/31/23  164:25M
 2/16/23  ConocoPhillips                    10-K       12/31/22  158:28M
 2/17/22  ConocoPhillips                    10-K       12/31/21  171:23M                                    Certent, Inc./FA
 2/16/21  ConocoPhillips                    10-K       12/31/20  173:24M                                    Certent, Inc./FA
Top
Filing Submission 0001193125-16-574165   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 3:45:44.2pm ET